Tag:
Inlyta
Latest Headlines
Latest Headlines
E.U. panel recommends Inlyta for adults with kidney cancer
E.U. regulators have recommended Pfizer's kidney cancer drug Inlyta be approved for use in patients who don't respond to other medications.
Pfizer nails unanimous expert panel vote for kidney cancer drug
Pfizer's ( $PFE ) cancer drug team nailed a unanimous endorsement from an FDA expert panel this morning following its review of axitinib , setting it on a path to a likely approval for patients with
